Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
OHSU Knight Cancer Institute
With
Oregon Health and Science University
PRIMARY OBJECTIVE:
I. To evaluate the effectiveness of VR therapy in reducing severity of anxiety symptoms during chemotherapy infusion, compared to participants utilizing a smartphone as a control.
SECONDARY OBJECTIVES:
I. To evaluate whether there is a short-term effect of VR use in anxiety levels.
II. To assess participant satisfaction with their chemotherapy infusion experience in the control and treatment groups.
EXPLORATORY OBJECTIVE:
I. To assess participants' reported adverse effects associated with VR headset use.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP 1: Patients use VR during chemotherapy infusion on study.
GROUP 2: Patients use smartphone during chemotherapy infusion on study.
Age
18–89
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
English speaking: Ability to interact with virtual reality content may be impacted by inability to understand English; moreover, paper questionnaires will only be provided in English.
Older than 18 years of age, and younger than 89 years of age. All sexes/gender identities and members of all races and ethnic groups will be included.
Planned to receive chemotherapy infusion for head and neck, breast, thoracic, and hematologic cancers at the Oregon Health \& Science University (OHSU) South Waterfront Center for Health \& Healing building 2 (there are no restrictions related to prior chemotherapy infusions or other cancer treatments).
Chemotherapy treatment lasting at least 10 minutes.
Ability to understand and willingness to sign a written informed consent document.
You may not be if
Social or psychiatric conditions that may interfere with compliance.
Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset. This would limit the ability to utilize the VR headset.
History of seizure or epilepsy.
History of vertigo or persistent dizziness.
Use of cardiac pacemaker, requirement for hearing aid on at all times, or have defibrillators.
